{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:08:12Z","timestamp":1791518892295,"version":"4.3.4"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T00:00:00Z","timestamp":1700352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Alcohol use can be significantly associated with negative social, professional, and health outcomes. Even more so, alcohol use disorder (AUD) is a critical public health issue and major avoidable risk factor. This study aimed to examine the effect of a naturalistic psychedelic experience on alcohol use and related measures.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A retrospective online survey was conducted on 160 individuals who reported a psychedelic experience and a concomitant drinking habit but did not necessarily have an AUD. Demographic data, characteristics of the psychedelic experience, and changes in alcohol consumption and psychological flexibility were surveyed. Results: The mean number of drinking days per week and AUDIT scores significantly decreased after the psychedelic experience (P\u2009&amp;lt;\u2009.001). Subjects who quit or reduced drinking had a more severe AUD (P\u2009&amp;lt;\u2009.01) and lower psychological flexibility (P\u2009=\u2009.003) before the psychedelic session. Alcohol use reduction was significantly associated with the intensity of the mystical experience (P\u2009=\u2009.03). Psychological flexibility increased more in participants who reduced their alcohol use (P\u2009&amp;lt;\u2009.001), and the change in psychological flexibility was one of the predictors of alcohol use improvement (P\u2009=\u2009.003). Conclusion: Our findings suggest that a naturalistic psychedelic experience could be associated with a reduction in alcohol use and dependency. Such positive health outcomes can be associated with the intensity of the mystical experience as well as an increase in psychological flexibility.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/alcalc\/agad078","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T01:12:20Z","timestamp":1700442740000},"source":"Crossref","is-referenced-by-count":16,"title":["Reduction of alcohol use and increase in psychological flexibility after a naturalistic psychedelic experience: a retrospective survey"],"prefix":"10.1093","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8090-0457","authenticated-orcid":false,"given":"Ewen","family":"Kervadec","sequence":"first","affiliation":[{"name":"APHP, Paul Brousse Hospital Department of Psychiatry and Addictology, , Villejuif F-94800 , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3525-3334","authenticated-orcid":false,"given":"Baptiste","family":"Fauvel","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9 Laboratoire M\u00e9moire, Cerveau et Cognition (UR 7536), Institut de Psychologie, , Site Boulogne-Centre Henri Pi\u00e9 ron71, avenue Edouard Vaillant 92774 Boulogne-Billancourt, Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9434-6226","authenticated-orcid":false,"given":"Lana","family":"Strika-Bruneau","sequence":"additional","affiliation":[{"name":"APHP, Paul Brousse Hospital Department of Psychiatry and Addictology, , Villejuif F-94800 , France"},{"name":"Unit\u00e9 de Recherche Psychiatrie-Comorbidit\u00e9s-Addictions\u2014PSYCOMADD\u2014Paris Saclay University \u00cele-de-France , H\u00f4pital Paul Brousse AP-HP12 Avenue Paul Vaillant Couturier, 94800 Villejuif , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Amirouche","sequence":"additional","affiliation":[{"name":"APHP, Paul Brousse Hospital Department of Psychiatry and Addictology, , Villejuif F-94800 , France"},{"name":"Unit\u00e9 de Recherche Psychiatrie-Comorbidit\u00e9s-Addictions\u2014PSYCOMADD\u2014Paris Saclay University \u00cele-de-France , H\u00f4pital Paul Brousse AP-HP12 Avenue Paul Vaillant Couturier, 94800 Villejuif , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Verroust","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de Recherche Psychiatrie-Comorbidit\u00e9s-Addictions\u2014PSYCOMADD\u2014Paris Saclay University \u00cele-de-France , H\u00f4pital Paul Brousse AP-HP12 Avenue Paul Vaillant Couturier, 94800 Villejuif , France"},{"name":"Universit\u00e9 Picardie-Jules Vernes , Chemin du Thil, 80000 Amiens , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Piolino","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9 Laboratoire M\u00e9moire, Cerveau et Cognition (UR 7536), Institut de Psychologie, , Site Boulogne-Centre Henri Pi\u00e9 ron71, avenue Edouard Vaillant 92774 Boulogne-Billancourt, Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3699-2024","authenticated-orcid":false,"given":"Bruno","family":"Romeo","sequence":"additional","affiliation":[{"name":"APHP, Paul Brousse Hospital Department of Psychiatry and Addictology, , Villejuif F-94800 , France"},{"name":"Unit\u00e9 de Recherche Psychiatrie-Comorbidit\u00e9s-Addictions\u2014PSYCOMADD\u2014Paris Saclay University \u00cele-de-France , H\u00f4pital Paul Brousse AP-HP12 Avenue Paul Vaillant Couturier, 94800 Villejuif , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amine","family":"Benyamina","sequence":"additional","affiliation":[{"name":"APHP, Paul Brousse Hospital Department of Psychiatry and Addictology, , Villejuif F-94800 , France"},{"name":"Unit\u00e9 de Recherche Psychiatrie-Comorbidit\u00e9s-Addictions\u2014PSYCOMADD\u2014Paris Saclay University \u00cele-de-France , H\u00f4pital Paul Brousse AP-HP12 Avenue Paul Vaillant Couturier, 94800 Villejuif , France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,11,19]]},"reference":[{"key":"2024011803334731500_ref1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jsat.2008.05.007","article-title":"Patient predictors of alcohol treatment outcome: a systematic review","volume":"36","author":"Adamson","year":"2009","journal-title":"J Subst Abuse Treat"},{"key":"2024011803334731500_ref3","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1176\/ajp.131.11.1247","article-title":"Peyote in the treatment of alcoholism among American Indians","volume":"131","author":"Albaugh","year":"1974","journal-title":"AJP"},{"key":"2024011803334731500_ref3a","edition":"5th ed."},{"key":"2024011803334731500_ref4","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/0269881115609019","article-title":"Validation of the revised mystical experience questionnaire in experimental sessions with psilocybin","volume":"29","author":"Barrett","year":"2015","journal-title":"J Psychopharmacol"},{"key":"2024011803334731500_ref5","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.encep.2020.12.002","article-title":"Efficacy of psychedelics in psychiatry, a systematic review of the literature","volume":"47","author":"Berkovitch","year":"2021","journal-title":"Encephale"},{"key":"2024011803334731500_ref6","article-title":"Changed substance use after psychedelic experiences among individuals in Canada","volume":"21","author":"Boehnke","year":"2023","journal-title":"Int J Ment Health Addiction"},{"key":"2024011803334731500_ref7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J Psychopharmacol"},{"key":"2024011803334731500_ref8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fphar.2018.00100","article-title":"Clinical interpretations of patient experience in a trial of psilocybin-assisted psychotherapy for alcohol use disorder","volume":"9","author":"Bogenschutz","year":"2018","journal-title":"Front Pharmacol"},{"key":"2024011803334731500_ref9","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial","volume":"79","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"2024011803334731500_ref10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.beth.2011.03.007","article-title":"Preliminary psychometric properties of the acceptance and action questionnaire\u2013II: a revised measure of psychological inflexibility and experiential avoidance","volume":"42","author":"Bond","year":"2011","journal-title":"Behav Ther"},{"key":"2024011803334731500_ref11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.118.017160","article-title":"REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics","volume":"71","author":"Carhart-Harris","year":"2019","journal-title":"Pharmacol Rev"},{"key":"2024011803334731500_ref12","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1177\/0269881117725915","article-title":"Serotonin and brain function: a tale of two receptors","volume":"31","author":"Carhart-Harris","year":"2017","journal-title":"J Psychopharmacol"},{"key":"2024011803334731500_ref13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"2024011803334731500_ref14","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N Engl J Med"},{"key":"2024011803334731500_ref15","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109398","article-title":"Canalization and plasticity in psychopathology","volume":"226","author":"Carhart-Harris","year":"2023","journal-title":"Neuropharmacology"},{"key":"2024011803334731500_ref15a","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jcbs.2020.01.005","article-title":"Psychedelics and psychological flexibility \u2013 Results of a prospective web-survey using the Acceptance and Action Questionnaire II","volume":"16","author":"Close","year":"2020","journal-title":"Journal of Contextual Behavioral Science"},{"key":"2024011803334731500_ref16","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1360-0443.1995.tb03552.x","article-title":"The AUDIT questionnaire: choosing a cut-off score","volume":"90","author":"Conigrave","year":"1995","journal-title":"Addiction"},{"key":"2024011803334731500_ref17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jcbs.2019.11.004","article-title":"Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety","volume":"15","author":"Davis","year":"2020","journal-title":"J Contextual Behav Sci"},{"key":"2024011803334731500_ref18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"2024011803334731500_ref19","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1111\/j.1530-0277.2007.00536.x","article-title":"Rates and correlates of relapse among individuals in remission from DSM-IV alcohol dependence: a 3-year follow-up","volume":"31","author":"Dawson","year":"2007","journal-title":"Alcoholism Clin Exp Res"},{"key":"2024011803334731500_ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2007.08.013","article-title":"The 14-year course of alcoholism in a community sample: do men and women differ?","volume":"93","author":"Edens","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"2024011803334731500_ref21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/02791072.2022.2059796","article-title":"Validation of a French version of the mystical experience questionnaire with retrospective reports of the most significant psychedelic experience among French users","volume":"55","author":"Fauvel","year":"2022","journal-title":"J Psychoactive Drugs"},{"key":"2024011803334731500_ref22","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1097\/01.alc.0000187034.58955.64","article-title":"The alcohol use disorders identification test (AUDIT) as a screening tool for excessive drinking in primary care: reliability and validity of a French version","volume":"29","author":"Gache","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"key":"2024011803334731500_ref23","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/0269881119845793","article-title":"Cessation and reduction in alcohol consumption and misuse after psychedelic use","volume":"33","author":"Garcia-Romeu","year":"2019","journal-title":"J Psychopharmacol"},{"key":"2024011803334731500_ref25","doi-asserted-by":"crossref","first-page":"106128","DOI":"10.1016\/j.addbeh.2019.106128","article-title":"The epidemiology of alcohol use disorders cross-nationally: findings from the world mental health surveys","volume":"102","author":"Glantz","year":"2020","journal-title":"Addict Behav"},{"key":"2024011803334731500_ref26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/7854_2021_298","volume-title":"Disruptive Psychopharmacology, Current Topics in Behavioral Neurosciences","author":"Golden","year":"2022"},{"key":"2024011803334731500_ref28","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J Psychopharmacol"},{"key":"2024011803334731500_ref28a","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbr.2014.07.016","article-title":"Recent advances in the neuropsychopharmacology of serotonergic hallucinogens","volume":"277","author":"Halberstadt","year":"2015","journal-title":"Behavioural Brain Research"},{"key":"2024011803334731500_ref29","volume-title":"Mindfulness and Acceptance: Expanding the Cognitive-Behavioral Tradition","author":"Hayes","year":"2004"},{"key":"2024011803334731500_ref30","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1177\/0269881114548296","article-title":"Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction","volume":"28","author":"Johnson","year":"2014","journal-title":"J Psychopharmacol"},{"key":"2024011803334731500_ref31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","article-title":"Long-term follow-up of psilocybin-facilitated smoking cessation","volume":"43","author":"Johnson","year":"2017","journal-title":"Am J Drug Alcohol Abuse"},{"key":"2024011803334731500_ref32","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1007\/s00213-020-05703-9","article-title":"Uncovering psychological mechanisms mediating the effects of drugs: some issues and comments using the example of psychedelic drugs","volume":"237","author":"Kangaslampi","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"key":"2024011803334731500_ref33","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cpr.2010.03.001","article-title":"Psychological flexibility as a fundamental aspect of health","volume":"30","author":"Kashdan","year":"2010","journal-title":"Clin Psychol Rev"},{"key":"2024011803334731500_ref34","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1177\/0269881112439253","article-title":"Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials","volume":"26","author":"Krebs","year":"2012","journal-title":"J Psychopharmacol"},{"key":"2024011803334731500_ref35","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1007\/s00213-016-4377-8","article-title":"Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking","volume":"233","author":"Kuypers","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"2024011803334731500_ref36","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","article-title":"Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels","volume":"44","author":"Madsen","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"2024011803334731500_ref37","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.erap.2009.09.001","article-title":"Traduction et validation fran\u00e7aise du questionnaire d\u2019acceptation et d\u2019action (AAQ-II)","volume":"59","author":"Monest\u00e8s","year":"2009","journal-title":"Eur Rev Appl Psychol"},{"key":"2024011803334731500_ref38","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1360-0443.2006.01310.x","article-title":"Rates and predictors of relapse after natural and treated remission from alcohol use disorders","volume":"101","author":"Moos","year":"2006","journal-title":"Addiction"},{"key":"2024011803334731500_ref39","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder","volume":"67","author":"Moreno","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"2024011803334731500_ref40","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fphar.2018.00132","article-title":"The psychedelic debriefing in alcohol dependence treatment: illustrating key change phenomena through qualitative content analysis of clinical sessions","volume":"9","author":"Nielson","year":"2018","journal-title":"Front Pharmacol"},{"key":"2024011803334731500_ref41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2020.03.020","article-title":"Psychedelic Psychiatry\u2019s brave new world","volume":"181","author":"Nutt","year":"2020","journal-title":"Cell"},{"key":"2024011803334731500_ref43","doi-asserted-by":"crossref","first-page":"1066369","DOI":"10.3389\/fpsyt.2022.1066369","article-title":"The association between naturalistic use of psychedelics and co-occurring substance use disorders","volume":"13","author":"Rabinowitz","year":"2023","journal-title":"Front Psych"},{"key":"2024011803334731500_ref44","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0140-6736(09)60746-7","article-title":"Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders","volume":"373","author":"Rehm","year":"2009","journal-title":"Lancet"},{"key":"2024011803334731500_ref45","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1177\/0269881120919957","article-title":"Efficacy of psychedelic treatments on depressive symptoms: a meta-analysis","volume":"34","author":"Romeo","year":"2020","journal-title":"J Psychopharmacol"},{"key":"2024011803334731500_ref46","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jpsychires.2021.03.002","article-title":"Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: a systematic review","volume":"137","author":"Romeo","year":"2021","journal-title":"J Psychiatr Res"},{"key":"2024011803334731500_ref47","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fphar.2017.00974","article-title":"Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression","volume":"8","author":"Roseman","year":"2018","journal-title":"Front Pharmacol"},{"key":"2024011803334731500_ref48","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J Psychopharmacol"},{"key":"2024011803334731500_ref50","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0306-4603(94)00072-7","article-title":"Initial motivations for alcohol treatment: relations with patient characteristics, treatment involvement, and dropout","volume":"20","author":"Ryan","year":"1995","journal-title":"Addict Behav"},{"key":"2024011803334731500_ref51","volume-title":"The Psychedelic Renaissance: Reassessing the Role of Psychedelic Drugs in 21st Century Psychiatry and Society","author":"Sessa","year":"2012"},{"key":"2024011803334731500_ref52","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.mehy.2012.09.021","article-title":"Early relapse in alcohol dependence may result from late withdrawal symptoms","volume":"79","author":"Simioni","year":"2012","journal-title":"Med Hypotheses"},{"key":"2024011803334731500_ref53","doi-asserted-by":"crossref","first-page":"204512532211353","DOI":"10.1177\/20451253221135363","article-title":"Classic psychedelics, health behavior, and physical health","volume":"12","author":"Simonsson","year":"2022","journal-title":"Ther Adv Psychopharmacol"},{"key":"2024011803334731500_ref54","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fphar.2018.00172","article-title":"Unifying theories of psychedelic drug effects","volume":"9","author":"Swanson","year":"2018","journal-title":"Front Pharmacol"},{"key":"2024011803334731500_ref55","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000446822","article-title":"Treatment seeking for alcohol use disorders: treatment gap or adequate self-selection?","volume":"22","author":"Tuithof","year":"2016","journal-title":"Eur Addict Res"},{"key":"2024011803334731500_ref56","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1511480","article-title":"Neurobiologic advances from the brain disease model of addiction","volume":"374","author":"Volkow","year":"2016","journal-title":"N Engl J Med"},{"key":"2024011803334731500_ref57","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"},{"key":"2024011803334731500_ref58","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/09540261.2018.1474088","article-title":"Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy","volume":"30","author":"Walsh","year":"2018","journal-title":"Int Rev Psychiatry"},{"key":"2024011803334731500_ref60a","volume-title":"Global status report on alcohol and health 2018","author":"World Health Organization"}],"container-title":["Alcohol and Alcoholism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/alcalc\/article-pdf\/59\/2\/agad078\/56168225\/agad078.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/alcalc\/article-pdf\/59\/2\/agad078\/56168225\/agad078.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T03:34:11Z","timestamp":1705548851000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/alcalc\/article\/doi\/10.1093\/alcalc\/agad078\/7429075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,19]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,1,17]]}},"URL":"https:\/\/doi.org\/10.1093\/alcalc\/agad078","relation":{},"ISSN":["0735-0414","1464-3502"],"issn-type":[{"value":"0735-0414","type":"print"},{"value":"1464-3502","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3]]},"published":{"date-parts":[[2023,11,19]]},"article-number":"agad078"}}